9/1/2022 7:43:34 AM
Vaxart Announces Positive Top-line Data From Phase II Study Of Wuhan S-Only COVID-19 Pill Vaccine Candidate
10/6/2021 8:07:44 AM
Vaxart?Begins Recruiting In Global Phase II COVID-19 Oral Tablet Vaccine Trial
12/22/2015 8:35:31 AM
FBR Capital Markets Starts Biota Pharmaceuticals Inc. (BOTA) At Outperform With $6 Price Target